Jeffrey Del Carmen insider trades
Open-market stock purchases and sales by Jeffrey Del Carmen, Chief Commercial Officer at Catalyst Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 30, 2020.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 29, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Sold (not open market) | — |
| Dec 29, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 8, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Sold (not open market) | — |
| Dec 8, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Bought (not open market) | — |
| Nov 26, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Bought (not open market) | — |
| Nov 26, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Sold | $256K |
| Nov 21, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Sold (not open market) | — |
| Nov 21, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Bought (not open market) | — |
| Nov 20, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Bought (not open market) | — |
| Nov 20, 2025 | CPRX Catalyst Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- CPRX Catalyst Pharmaceuticals, Inc: 10 sales, last Dec 29, 2025